Financial results - LADYS DOCTOR S.R.L.

Financial Summary - Ladys Doctor S.r.l.
Unique identification code: 28102540
Registration number: J23/497/2011
Nace: 8622
Sales - Ron
99.657
Net Profit - Ron
84.691
Employee
1
The most important financial indicators for the company Ladys Doctor S.r.l. - Unique Identification Number 28102540: sales in 2023 was 99.657 euro, registering a net profit of 84.691 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Ladys Doctor S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 35.707 37.131 45.495 47.699 45.496 50.732 55.271 72.406 76.753 99.657
Total Income - EUR 35.707 37.131 45.685 47.699 45.496 50.732 55.675 72.475 76.753 99.657
Total Expenses - EUR 5.506 7.081 6.661 7.828 10.043 10.717 8.952 13.853 9.678 13.989
Gross Profit/Loss - EUR 30.201 30.049 39.024 39.872 35.453 40.015 46.723 58.622 67.075 85.667
Net Profit/Loss - EUR 29.130 28.935 37.654 38.988 34.998 39.508 46.210 57.982 66.325 84.691
Employees 1 1 1 1 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 30.2%, from 76.753 euro in the year 2022, to 99.657 euro in 2023. The Net Profit increased by 18.567 euro, from 66.325 euro in 2022, to 84.691 in the last year.

Check the financial reports for the company - Ladys Doctor S.r.l.

Rating financiar

Financial Rating -
Ladys Doctor S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Ladys Doctor S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Ladys Doctor S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Ladys Doctor S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Ladys Doctor S.r.l. - CUI 28102540

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 4.541 3.460 2.744 2.521 3.197 2.073 2.298 2.114 1.961 1.762
Current Assets 27.013 29.163 37.050 66.757 39.076 77.452 51.660 64.771 73.575 84.138
Inventories 331 76 0 45 349 431 0 0 0 3.627
Receivables 70 129 0 3.992 82 615 0 590 40.393 63.110
Cash 26.612 28.958 37.050 62.720 38.644 76.405 51.660 64.181 33.182 17.401
Shareholders Funds 29.183 28.989 37.708 39.041 35.050 39.558 46.260 58.031 66.373 84.739
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 2.372 3.634 2.086 30.237 7.223 39.967 7.698 8.855 9.162 1.161
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 84.138 euro in 2023 which includes Inventories of 3.627 euro, Receivables of 63.110 euro and cash availability of 17.401 euro.
The company's Equity was valued at 84.739 euro, while total Liabilities amounted to 1.161 euro. Equity increased by 18.567 euro, from 66.373 euro in 2022, to 84.739 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Ladys Doctor S.r.l.

Comments - Ladys Doctor S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.